Sanofi Genzyme Corp 50 Binney Streetcambridge Ma 02142 Pma Numberp940015 Supplement Numbers050 Date Received09 30 2022 Decision Date11 04 2022 Product Code Moz Advisory Committee Orthopedic Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Sanofi Genzyme Corp 50 Binney Streetcambridge Ma 02142 Pma Numberp940015 Supplement Numbers050 Date Received09 30 2022 Decision Date11 04 2022 Product Code Moz Advisory Committee Orthopedic Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P940015S050 Sanofi GENZYME CORP.50 Binney Streetcambridge, MA 02142 PMA NumberP940015 Supplement NumberS050 Date Received09/30/2022 Decision Date11/04/2022 Product Code MOZ  Advisory Committee Orthopedic Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	Synvisc and Synvisc-One	2022-11-04